Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Xenotransplantation. 2014 Mar 20;21(3):244–253. doi: 10.1111/xen.12091

Figure 3. The anti-nonGal xenoantibody response to genetically modified porcine islets is restricted.

Figure 3

Figure 3

Figure 3

Figure 3

(A) The usage of the immunoglobulin heavy chain gene IGHV3-66*02 was elevated from 7%±0% in pretransplant baboon serum to 35%±6% post-islet cell transplantation. (B) The nucleotide sequence of four representative IGVH genes encoding IgM anti-nonGal xenoantibodies is shown. The IGVH genes encoding anti-nonGal porcine islet xenoantibodies is shown compared to the sequence of the IGHV3-21*01 germline gene which encodes anti-nonGal xenoantibodies to GTKO pig endothelial cells without multiple genetic modifications. (C) The amino acid sequence of IGVH genes encoding anti-nonGal xenoantibodies to genetically modified pig islets is shown. The regions of the CDR1 and CDR2 which are conserved may be relevant for contact with nonGal xenoantigen. (−) Identical residues when compared with the closest human germline gene. FWR (framework region) CDR (complementary determining region).